Systemic Triple Therapy in Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
For many years, androgen deprivation therapy (ADT) as monotherapy has been the gold standard for metastatic hormone-sensitive prostate cancer (mHSPC) treatment.Several studies have been published within Aloe Vera the last decade demonstrating a significant survival advantage resulting from combining the treatment with standard ADT plus docetaxel or